Next Article in Journal
Efficacy and Safety of Artificial Tears Containing Lipidure and Hypromellose for the Treatment of Moderate Dry Eye Disease in Contact Lens Wearers
Next Article in Special Issue
Comparative Analysis of Right vs. Left Radial Access in Percutaneous Coronary Intervention: Impact on Silent Cerebral Ischemia
Previous Article in Journal
Psycho-Neuroendocrinology in the Rehabilitation Field: Focus on the Complex Interplay between Stress and Pain
Previous Article in Special Issue
Prevalence of Cardiovascular Comorbidities in Patients with Rheumatoid Arthritis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

One-Year Outcomes of CGuard Double Mesh Stent in Carotid Artery Disease: A Systematic Review and Meta-Analysis

by
Konstantinos Tigkiropoulos
1,*,†,
Spyridon Nikas
2,†,
Abatzis-Papadopoulos Manolis
1,
Katerina Sidiropoulou
1,
Kyriakos Stavridis
1,
Dimitrios Karamanos
1,
Ioannis Lazaridis
1 and
Nikolaos Saratzis
1
1
Division of Vascular Surgery, 1st Surgical Department, Faculty of Health Sciences, Papageorgiou General Hospital, Aristotle University, 56403 Thessaloniki, Greece
2
Department of Radiology, Papageorgiou General Hospital, 56403 Thessaloniki, Greece
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Medicina 2024, 60(2), 286; https://doi.org/10.3390/medicina60020286
Submission received: 9 January 2024 / Revised: 2 February 2024 / Accepted: 5 February 2024 / Published: 8 February 2024
(This article belongs to the Special Issue The Challenges and Prospects in Clinical Cardiology and Angiology)

Abstract

Background: Prospective single and multicenter studies have shown improved outcomes of patients who underwent carotid artery stenting with the novel CGuard dual-layer mesh stent at 1 year. Objectives: The aim of this study is to conduct a systematic review and meta-analysis of all published studies to assess 1-year efficacy and outcomes of CGuard in patients with carotid stenting. Methods: A systematic search was performed. All studies enrolling at least 20 patients were included in our analysis. The primary endpoints were death (all-cause, cardiovascular and ipsilateral stroke-related death) and stroke rate at 1 year. The secondary endpoint was in-stent restenosis at 1 year. Results: The final analysis included 1709 patients. The one-year all-cause mortality rate was 2.97% (39/1699, 95% CI: 1.26–6.86%, I2 = 67%, t2 = 0.3442, p < 0.01), cardiovascular-related death was 0.92% (10/1616, 95% CI: 0.35–2.39%, I2 = 34%, t2 = 0.2302, p = 0.18), and ipsilateral stroke-related death was 0.3% (1/1649, 95% CI: 0.1–0.87%, I2 = 0%, t2 = 0, p = 0.69). The one-year ipsilateral stroke rate was 1.21% (16/1649, 95% CI: 0.58–2.5%, I2 = 28%, t2 = 0.1433, p = 0.23), transient ischemic attacks (TIAs) rate was 1.78% (19/1149, 95% CI: 1.11–2.84%, I2 = 0%, t2 = 0, p = 0.69), and total composite 1-year stroke/TIA rate was 2.97% (32/1149, 95% CI: 1.84–4.77%, I2 = 0%, t2 = 0, p = 0.41). The in-stent restenosis rate at 1 year was 1.06% (13/1653, 95% CI: 0.48–2.34%, I2 = 28%, t2 = 0.2308, p = 0.22). Conclusions: This meta-analysis shows that CAS with CGuard is safe with minimal neurological adverse events and in-stent restenosis rate at 1 year.
Keywords: CGuard; carotid artery stenting; carotid artery disease; dual layer mesh stents; systematic review and meta-analysis CGuard; carotid artery stenting; carotid artery disease; dual layer mesh stents; systematic review and meta-analysis

Share and Cite

MDPI and ACS Style

Tigkiropoulos, K.; Nikas, S.; Manolis, A.-P.; Sidiropoulou, K.; Stavridis, K.; Karamanos, D.; Lazaridis, I.; Saratzis, N. One-Year Outcomes of CGuard Double Mesh Stent in Carotid Artery Disease: A Systematic Review and Meta-Analysis. Medicina 2024, 60, 286. https://doi.org/10.3390/medicina60020286

AMA Style

Tigkiropoulos K, Nikas S, Manolis A-P, Sidiropoulou K, Stavridis K, Karamanos D, Lazaridis I, Saratzis N. One-Year Outcomes of CGuard Double Mesh Stent in Carotid Artery Disease: A Systematic Review and Meta-Analysis. Medicina. 2024; 60(2):286. https://doi.org/10.3390/medicina60020286

Chicago/Turabian Style

Tigkiropoulos, Konstantinos, Spyridon Nikas, Abatzis-Papadopoulos Manolis, Katerina Sidiropoulou, Kyriakos Stavridis, Dimitrios Karamanos, Ioannis Lazaridis, and Nikolaos Saratzis. 2024. "One-Year Outcomes of CGuard Double Mesh Stent in Carotid Artery Disease: A Systematic Review and Meta-Analysis" Medicina 60, no. 2: 286. https://doi.org/10.3390/medicina60020286

APA Style

Tigkiropoulos, K., Nikas, S., Manolis, A.-P., Sidiropoulou, K., Stavridis, K., Karamanos, D., Lazaridis, I., & Saratzis, N. (2024). One-Year Outcomes of CGuard Double Mesh Stent in Carotid Artery Disease: A Systematic Review and Meta-Analysis. Medicina, 60(2), 286. https://doi.org/10.3390/medicina60020286

Article Metrics

Back to TopTop